Your browser does not support JavaScript!

Matières premières

351 entreprises et organismes intervenants dans le domaine 'Matières premières', classés par activité.

Rejoignez la communauté
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Aujourd'hui à 15:43

Roche to develop new dMMR pan-cancer test for Merck’s Keytruda immunotherapy

Hier à 19:40
If you can’t beat 'em, join 'em: Roche is teaming up with its immuno-oncology competitor Merck & Co. to develop a pan-cancer companion diagnostic test for its Keytruda therapy aimed at...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 3 jours

Merck KGaA taps Cyclica for AI-based screening of protein-drug interactions

Il y a 6 jours
Merck KGaA has licensed a cloud-based artificial intelligence proteome screening platform from the Toronto-based Cyclica....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de L'Usine Nouvelle
Il y a 2 semaines

Merck mobilise 30 millions d'euros contre le diabète

Il y a 2 semaines
Le laboratoire allemand Merck va construire une extension de son usine de Semoy (Loiret) pour 19 millions d'euros. Il vient d'achever un programme de 11 millions... - Quotidien des Usines
www.usinenouvelle.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 3 semaines

Merck KGaA, Palantir form new JV aimed at breaking down cancer data silos

Il y a 3 semaines
Merck KGaA is launching a new joint venture with the tech firm Palantir, built around a collaboration platform for cancer research and discovery....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 08/11/2018

SITC18: Merck highlights new LAG-3 and TIGIT data

Le 07/11/2018
The SITC conference kicks off today with a stack of new data on immuno-oncology drugs, including a first look at Merck & Co.’s early-stage drugs targeting LAG-3 and TIGIT....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 02/10/2018

Dragonfly Therapeutics in $695M cancer R&D pact with Merck

Le 01/10/2018
More than a year after insect-inspired biotech Dragonfly Therapeutics penned a blood cancer pact with big biotech Celgene, it's back at the deal table with a potentially meaty biobucks deal with...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 24/09/2018

Agenus sells cut of Incyte, Merck milestone streams

Le 21/09/2018
Agenus has sold a portion of the royalties and milestones it is due to receive from Incyte and Merck. Xoma is paying $15 million for 10% of the $600 million in milestones Agenus is in line to pocket...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de Labiotech.eu
Le 18/09/2018

The Merck Advance Biotech Grant Program: Nurturing the Seeds of Innovative Therapies

Le 17/09/2018
Development of innovative therapies is mostly carried out by small and mid-size biotechs. Often however, the financial burden becomes too heavy just when the new molecule is ready to move to the...
labiotech.eu
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 27/08/2018

Merck KGaA, GlucoMe to pilot remote, digital diabetes care in Vietnam

Le 24/08/2018
Merck KGaA has tapped digital diabetes platform provider GlucoMe for a pilot collaboration in several hospitals across Vietnam, the country with the fastest-growing rate of the disease in Southeast...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 07/08/2018

Merck, HitGen expand DNA library screening collaboration

Le 06/08/2018
Merck and HitGen have upsized their licensing agreement into a full-fledged, multiyear drug discovery collaboration, with plans to screen DNA-encoded libraries for new small molecule assets....
www.fiercebiotech.com
Charger plus d'actualités